EComment. Interpretation of the data together with the management of cardiac surgery patients with diabetes mellitus

Basit Öğe Kaydı
dc.authorid0000-0002-9815-1848
dc.authorid0000-0002-0799-4875
dc.contributor.authorÖzyüksel, Arda
dc.contributor.authorÖlmüşçelik, Oktay
dc.contributor.authorKayan, Ekin
dc.contributor.authorAkçevin, Atıf
dc.date.accessioned10.07.201910:49:13
dc.date.accessioned2019-07-10T19:56:29Z
dc.date.available10.07.201910:49:13
dc.date.available2019-07-10T19:56:29Z
dc.date.issued2013
dc.departmentİstanbul Medipol Üniversitesi, Tıp Fakültesi, Cerrahi Tıp Bilimleri Bölümü, Kalp ve Damar Cerrahisi Ana Bilim Dalı
dc.departmentİstanbul Medipol Üniversitesi, Tıp Fakültesi, Cerrahi Tıp Bilimleri Bölümü, Çocuk Cerrahisi Ana Bilim Dalı
dc.departmentİstanbul Medipol Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, İç Hastalıkları Ana Bilim Dalı
dc.descriptionWOS: 000327456100026
dc.descriptionPubMed ID: 24243950
dc.description.abstractWe have read with interest the analysis by Tennyson et al. of the role of HbA1c in predicting the mortality and morbidity outcomes in patients undergoing coronary artery bypass surgery (CABG) [1]. In such patients, higher fasting blood glucose (FPG) levels are associated with a higher incidence of arrhythmia, atelectasis and prolonged mechanical ventilation, whereas higher HbA1c levels are associated with a higher incidence of intra-aortic balloon counterpulsation, massive bleeding and multi-organ failure [2]. Although diabetes mellitus (DM) is traditionally known to be associated with an increased risk for CABG, there are also adverse outcomes reported in the literature indicating similar hospital mortality rates for diabetic and non-diabetic patient groups [3]. In fact, delaying the surgical procedure seems to be the safest measure when quadrupled mortality for CABG is noted with HbA1c values of over 8.6% [1]. Since the lifespan of red blood cells is around three months, any effective change in HbA1c levels will be assumed to take place within 10-12 weeks. So, the question is about which parameters we are able to manipulate in a patient with altered FBG levels who are candidates for a CABG procedure and how we can interpret and evaluate the HbA1c and FPG levels in these patients. In our clinical practice we put all DM patients who are on oral hypoglycaemic drugs onto dual insulin treatment in the preoperative period without taking HbA1c levels into account.
dc.identifier.citationÖzyüksel, A., Ölmüşçelik, O., Kayan, E. ve Akçevin, A. (2013). EComment. Interpretation of the data together with the management of cardiac surgery patients with diabetes mellitus. Interactive Cardiovascular And Thoracic Surgery, 270(11), 2901-2907. https://dx.doi.org/10.1093/icvts/ivt470
dc.identifier.doi10.1093/icvts/ivt470
dc.identifier.endpage1008
dc.identifier.issn1569-9293
dc.identifier.issn1569-9285
dc.identifier.issue6
dc.identifier.scopusqualityQ2
dc.identifier.startpage1008
dc.identifier.urihttps://dx.doi.org/10.1093/icvts/ivt470
dc.identifier.urihttps://hdl.handle.net/20.500.12511/2720
dc.identifier.volume17
dc.identifier.wosqualityQ3
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherOxford Univ Press
dc.relation.ispartofInteractive Cardiovascular And Thoracic Surgeryen_US
dc.relation.publicationcategoryDiğer
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectEComment
dc.subjectInterpretation of the Data Together
dc.subjectManagement of Cardiac
dc.subjectSurgery Patients
dc.subjectDiabetes Mellitus
dc.titleEComment. Interpretation of the data together with the management of cardiac surgery patients with diabetes mellitus
dc.typeLetter

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim
İsim:
Ozyuksel-Arda 2013.pdf
Boyut:
72.23 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin/Full Text
İndir

Koleksiyon

Scopus İndeksli Yayınlar Koleksiyonu
Diğer Yayınlar Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
WoS İndeksli Yayınlar Koleksiyonu